METASTATIC CERVICAL CARCINOMA
Clinical trials for METASTATIC CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against tough cervical cancer
Disease control OngoingThis study tests whether combining two drugs, dostarlimab and cobolimab, can shrink tumors or slow the disease in people with advanced or recurrent cervical cancer. About 66 participants with measurable tumors will receive the combination. The main goal is to see how many patient…
Matched conditions: METASTATIC CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
New immune cell therapy targets five Hard-to-Treat cancers
Disease control TerminatedThis early-stage trial was designed to test the safety of a new treatment called STIL101 for people with advanced pancreatic, colorectal, kidney, cervical cancer, or melanoma that has spread or cannot be removed. The treatment uses a patient's own immune cells (T cells) taken fro…
Matched conditions: METASTATIC CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Blood test may tame Chemo's nerve damage
Knowledge-focused TerminatedThis study looks at whether doctors can consistently measure the chemotherapy drug paclitaxel in the blood of cancer patients. The goal is to see if this could help adjust doses to kill cancer while reducing nerve damage, a common side effect. About 22 adults with various solid t…
Matched conditions: METASTATIC CERVICAL CARCINOMA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 17, 2026 07:38 UTC
-
Blood test may predict cervical cancer treatment success
Knowledge-focused OngoingThis study collects blood samples from 18 people with cervical cancer to see if HPV DNA from the tumor can be detected in the blood. Researchers hope this information can help predict how well treatment works and catch cancer early if it comes back. The study is observational and…
Matched conditions: METASTATIC CERVICAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC